FOSTER ANDREW B

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 26

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,462

F1 · kind: These shares were withheld by the Issuer in connection with the Reporting Persons exercise of stock options.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 19

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,190

F1 · kind: These shares were withheld by the Issuer in connection with the Reporting Persons exercise of stock options.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 18

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 254,708

F1 · kind: These shares were withheld by the Issuer in connection with the Reporting Persons exercise of stock options.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 4

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,404

F1 · kind: These shares were withheld by the Issuer in connection with the Reporting Persons exercise of stock options.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 2

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 221,404

F1 · kind: These shares were withheld by the Issuer in connection with the Reporting Persons exercise of stock options.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-000983 · primary_01.xml · derivative · entry 3

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,788

Underlying: Common stock and Series B Preferred · 30,500 shares

Expires 2029-01-07

SEC source: 0001593968-21-000983 · primary_01.xml · derivative · entry 2

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,681

Underlying: Common stock and Series B Preferred · 0 shares

Expires 2028-01-18

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 25

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,411

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-000983 · primary_01.xml · derivative · entry 4

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,581

Underlying: Common stock and Series B Preferred · 7,419 shares

Expires 2030-03-28

SEC source: 0001593968-21-000983 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,619

Underlying: Common stock and Series B Preferred · 48,319 shares

Expires 2028-01-18

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 24

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,561

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 17

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,361

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-000957 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,000

Underlying: Common stock and Series B Preferred · 37,500 shares

Expires 2030-03-28

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 23

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,973

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 20

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,973

F1 · kind: These shares were withheld by the Issuer in connection with the Reporting Persons exercise of stock options.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 10

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,554

F1 · kind: These shares were withheld by the Issuer in connection with the Reporting Persons exercise of stock options.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-000384 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2023-05-17

F1 · price: The 10,000 shares were exercised from grant 5/17/2018 and sold through executing the 10b5-1 plan.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 15

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,235

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-000358 · primary_01.xml · derivative · entry 2

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2023-05-17

F1 · price: The 10,000 shares were exercised from grant 5/17/2018 and sold through executing the 10b5-1 plan.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 14

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,235

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-000358 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2023-05-17

F1 · price: The 10,000 shares were exercised from grant 5/17/2018 and sold through executing the 10b5-1 plan.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 13

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,235

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-000344 · primary_01.xml · derivative · entry 3

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2023-05-17

F2 · price: The 10,000 shares were exercised from grant 5/17/2018 and sold through executing the 10b5-1 plan.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 12

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,235

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-000344 · primary_01.xml · derivative · entry 2

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common stock and Series B Preferred · 5,000 shares

Expires 2023-05-17

F2 · price: The 10,000 shares were exercised from grant 5/17/2018 and sold through executing the 10b5-1 plan.

SEC source: 0001593968-21-000344 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common stock and Series B Preferred · 5,000 shares

Expires 2028-01-18

F1 · price: The 10,000 shares were exercised from grant 1/18/2018 and sold through executing the 10b5-1 plan.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 11

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,235

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 9

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,235

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-000296 · primary_01.xml · derivative · entry 2

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common stock and Series B Preferred · 65,000 shares

Expires 2028-01-18

F1 · price: The 10,000 shares were exercised from grant 1/18/2018 and sold through executing the 10b5-1 plan.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 8

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,235

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-000296 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common stock and Series B Preferred · 75,000 shares

Expires 2028-01-18

F1 · price: The 10,000 shares were exercised from grant 1/18/2018 and sold through executing the 10b5-1 plan.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 7

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,235

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-000252 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2028-01-18

F1 · price: The 10,000 shares were exercised from grant 1/18/2018 and sold through executing the 10b5-1 plan.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 6

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,235

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-000248 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common stock and Series B Preferred · 85,000 shares

Expires 2028-01-18

F1 · price: The 10,000 shares were exercised from grant 1/18/2018 and sold through executing the 10b5-1 plan.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 5

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,235

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-000224 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common stock and Series B Preferred · 5,000 shares

Expires 2029-01-07

F1 · price: The 10,000 shares were exercised from grant 1/8/2019 and sold through executing the 10b5-1 plan.

SEC source: 0001593968-21-000221 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,000

Underlying: Common stock and Series B Preferred · 15,000 shares

Expires 2028-01-18

F1 · price: The 10,000 shares were exercised from grant 1/18/2018 and sold through executing the 10b5-1 plan.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 16

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,235

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-000183 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2029-01-07

F1 · price: The 10,000 shares were exercised from grant 1/8/2019 and sold through executing the 10b5-1 plan.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 22

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,235

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-000104 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common stock and Series B Preferred · 125,000 shares

Expires 2031-01-07

F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

F2 · derivative.underlying_shares: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 125,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $3.09 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

F2 · balance_after: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 125,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $3.09 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

SEC source: 0001593968-20-002094 · primary_01.xml · nonDerivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The 10,000 shares each from 11-16-2017 option grant and 01-08-2019 option grant were exercised and sold through 10b5-1 plan sold as below 10/21/20 - exercised 10,000 and sold at $4.50 per share 10/22/20 - exercised 10,000 and sold at $5.01 per share. The average price was used for 20,000 shares in this cell.

SEC source: 0001593968-20-002090 · primary_01.xml · nonDerivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The 11-16-2017 option grant was exercised and sold through 10b5-1 plan sold as below 10/19/20 - exercised 10,000 and sold at $4.50 per share 10/20/20 - exercised 10,000 and sold at $4.54 per share. The average price was used for 20,000 shares in this cell.

SEC source: 0001593968-20-000917 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common stock and Series B Preferred · 150,000 shares

Expires 2030-03-28

F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

F2 · derivative.underlying_shares: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 150,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.60 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

F2 · balance_after: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 150,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.60 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

SEC source: 0001593968-20-000141 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common stock and Series B Preferred · 100,000 shares

Expires 2030-01-09

F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

F2 · derivative.underlying_shares: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 100,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.86 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

F2 · balance_after: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 100,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.86 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

SEC source: 0001593968-19-001373 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common stock and Series B Preferred · 60,000 shares

Expires 2029-06-05

F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

F2 · derivative.underlying_shares: Grant of Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 60,000 shares of the Company's Common Stock ("Option Shares") at and Exercise Price of $0.92 per share, and subject to the terms of the Stock Option Agreement between Reporting Person and the Company.

F2 · balance_after: Grant of Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 60,000 shares of the Company's Common Stock ("Option Shares") at and Exercise Price of $0.92 per share, and subject to the terms of the Stock Option Agreement between Reporting Person and the Company.

SEC source: 0001593968-19-000142 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common stock and Series B Preferred · 100,000 shares

Expires 2029-01-07

F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

F2 · derivative.underlying_shares: Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 100,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.70 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

F2 · balance_after: Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 100,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.70 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

SEC source: 0001593968-18-000797 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common stock and Series B Preferred · 60,000 shares

Expires 2023-05-17

F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

F2 · derivative.underlying_shares: Grant of Qualified Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 60,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $1.71 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

F2 · balance_after: Grant of Qualified Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 60,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $1.71 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

SEC source: 0001593968-18-000177 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common stock and Series B Preferred · 100,000 shares

Expires 2028-01-18

F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

F2 · derivative.underlying_shares: Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 100,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.70 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

F2 · balance_after: Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 100,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.70 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.